| 1 | | Primary 35 CambridgePark Dr | Cambridge |  US | | Leaders In Exosome Therapeutics | N/A | Aaron Noyes | Director at Codiak BioSciences |
| 2 | | Primary 490 Lapp Rd | Malvern | US | | Advancing Acute Care Therapeutics | N/A | melinda spears | director of recruitment, training and development |
| 3 | | Primary 500 W 2nd St | Delta | US | | Craft Cbd Therapeutics | N/A | Jackson Tine | Owner at Hope CBD |
| 4 | | Primary 383 S Colorow Dr | Salt Lake City | US | | Discovering and Developing D-Peptide Therapeutics | N/A | Neil Berkley | Vice President, Head of Business Development at Halozyme Therapeutics, Inc. |
| 5 | | Primary | New York City | US | | Translating Molecules Into Therapeutics | N/A | Alain Stricker-Krongrad | C.E.O. at Envol Biomedical |
| 6 | | Primary 12705 E Montview Blvd Ste. 350 | Aurora | US | | Therapeutics By Design | N/A | Kathleen Burkepile | Student at University of Colorado Boulder |
| 7 | | Primary | Miami | US | | Therapeutics In Degenerative Disease | N/A | Maxim Temnikov | --sell technology |
| 8 | | Primary 681 Gateway Blvd Suite 313 | South San Francisco | US | | Delivering Next Generation Genetic Therapeutics | N/A | Deepak Gupta | Managing Partner at Blue Bear Ventures |
| 9 | | Primary | San Francisco | US | | Transformative Therapeutics From Medicine's Roots | N/A | Ed Wiley, PhD | CTO | CIO | Data Science/Machine Learning Executive | Artificial Intelligence Expert | Board Advisor | Keynote Speaker |
| 10 | | Primary | Cambridge | US | | Redefining Cancer Therapeutics | N/A | scott robinson | president and chief strategy officer |
| 11 | | Primary One Rockefeller Plaza, 10th FL | New York | US | | Focused On Unique Targeted Therapeutics | N/A | Hayley Behrmann | VP of Operations at Hoth Therapeutics, Inc |
| 12 | | Primary 245 Main St | Cambridge | US | | Develop Life-Changing Therapeutics For Cancer | N/A | N/A | N/A |
| 13 | | Primary | Los Altos | US | | Precision Therapeutics For Brain Health | N/A | Lauren Blake, Ph.D. | Data Scientist at Alto Neuroscience |
| 14 | | Primary 1840 Century Park E 801 | Los Angeles | US | | Pioneering Virtual Reality Therapeutics | N/A | matthew stoudt | Chief Executive Officer |
| 15 | | Primary 101 Avenue of the Americas | New York | US | | Lifelong, Resistance-Proof Therapeutics | N/A | Sayantan Bose | Senior Scientist, Virology at Autonomous Therapeutics • Former Research Fellow At Harvard Medical School |
| 16 | | Primary 3401 Market St | Philadelphia | US | | Discovering Novel Antiviral Therapeutics | N/A | Michael Saporito | Biopharmaceutical Consultant |
| 17 | | Primary 200 Crescent Court Suite 455 | Dallas | US | | Hedge Fund Focused On Biotech/Pharma/Therapeutics | N/A | Neil Shahrestani, MD | Portfolio Manager - Biotech/Therapeutics |
| 18 | | Primary 300 Brookside Ave | Lower Gwynedd Township | US | | A Gyroscope Therapeutics Company | N/A | Rose McKinley | Vice President, Human Resources & Organizational Development |
| 19 | | Primary 1 Broadway Fl 14 | Cambridge | US | | An Immune-Driven Global Bio-Therapeutics Company | N/A | musheng bao | Director |
| 20 | | Primary 25350 Magic Mountain Pkwy Suite #300 | Santa Clarita | US | | Digital Therapeutics For Hearing | N/A | Daehee Lee | GoldenEar Company, Inc. CEO |
